_id
690dad62ccc777a4e85d0a07
Ticker
ALLR
Name
Allarity Therapeutics Inc
Exchange
NASDAQ
Address
24 School Street, Boston, MA, United States, 02108
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.allarity.com
Description
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Last Close
1.17
Volume
19969
Current Price
1.14
Change
-0.04
Last Updated
2026-01-20T15:12:05.410Z
Image
data:image/webp;base64,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
Ipo Date
2021-12-21T00:00:00.000Z
Market Cap
17283656
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.993
Sentiment Sources
1
Rating
3
Target Price
9.25
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2518000
Operating Income
-2518000
Interest Expense
57000
Pretax Income
-2806000
Net Income
-2806000
Eps
-0.19036893309271496
Dividends Per Share
-
Shares Outstanding
14524080
Income Tax Expense
-
EBITDA
-2749000
Operating Margin
-
Total Other Income Expense Net
-288000
Cash
16895000
Short Term Investments
-
Receivables
1662000
Inventories
-
Total Current Assets
20466000
Property Plant Equipment
330000
Total Assets
20796000
Payables
4602000
Short Term Debt
1390000
Long Term Debt
-
Total Liabilities
8785000
Equity
12011000
Bs_currency_symbol
USD
Depreciation
-44000
Change In Working Capital
-816000
Cash From Operations
-3410000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2310000
Net Change In Cash
-906000
Cf_currency_symbol
USD
PE
0.207
PB
1.3989985846307549
ROE
-23.361918241611857
ROA
-13.492979419119061
FCF
-3410000
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3.5
Quality Investing Score
2.5
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2518000
Quarters > 0 > income Statement > operating Income
-2518000
Quarters > 0 > income Statement > interest Expense
57000
Quarters > 0 > income Statement > pretax Income
-2806000
Quarters > 0 > income Statement > net Income
-2806000
Quarters > 0 > income Statement > eps
-0.19036893309271496
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
14739800
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2749000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-288000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
16895000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1662000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
20466000
Quarters > 0 > balance Sheet > property Plant Equipment
330000
Quarters > 0 > balance Sheet > total Assets
20796000
Quarters > 0 > balance Sheet > payables
4602000
Quarters > 0 > balance Sheet > short Term Debt
1390000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
8785000
Quarters > 0 > balance Sheet > equity
12011000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2806000
Quarters > 0 > cash Flow > depreciation
-44000
Quarters > 0 > cash Flow > change In Working Capital
-816000
Quarters > 0 > cash Flow > cash From Operations
-3410000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2310000
Quarters > 0 > cash Flow > net Change In Cash
-906000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.19036893309271496
Quarters > 0 > ratios > PB
1.3989985846307549
Quarters > 0 > ratios > ROE
-23.361918241611857
Quarters > 0 > ratios > ROA
-13.492979419119061
Quarters > 0 > ratios > FCF
-3410000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
12000
Quarters > 1 > income Statement > gross Profit
-12000
Quarters > 1 > income Statement > operating Expenses
4133000
Quarters > 1 > income Statement > operating Income
-4133000
Quarters > 1 > income Statement > interest Expense
12000
Quarters > 1 > income Statement > pretax Income
-2320000
Quarters > 1 > income Statement > net Income
-2320000
Quarters > 1 > income Statement > eps
-0.14926025139672533
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15543321
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2296000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1813000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
17801000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1609000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
20883000
Quarters > 1 > balance Sheet > property Plant Equipment
322000
Quarters > 1 > balance Sheet > total Assets
21205000
Quarters > 1 > balance Sheet > payables
4605000
Quarters > 1 > balance Sheet > short Term Debt
1375000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9038000
Quarters > 1 > balance Sheet > equity
12167000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2320000
Quarters > 1 > cash Flow > depreciation
12000
Quarters > 1 > cash Flow > change In Working Capital
-3420000
Quarters > 1 > cash Flow > cash From Operations
-5481000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-2565000
Quarters > 1 > cash Flow > net Change In Cash
-9903000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.14926025139672533
Quarters > 1 > ratios > PB
1.4563479855346426
Quarters > 1 > ratios > ROE
-19.067970740527656
Quarters > 1 > ratios > ROA
-10.9408158453195
Quarters > 1 > ratios > FCF
-5481000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
11000
Quarters > 2 > income Statement > gross Profit
-11000
Quarters > 2 > income Statement > operating Expenses
3036000
Quarters > 2 > income Statement > operating Income
-3036000
Quarters > 2 > income Statement > interest Expense
57000
Quarters > 2 > income Statement > pretax Income
-2732000
Quarters > 2 > income Statement > net Income
-2732000
Quarters > 2 > income Statement > eps
-2.4509012354982365
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1114692
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2664000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
304000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
25201000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1115000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
29422000
Quarters > 2 > balance Sheet > property Plant Equipment
308000
Quarters > 2 > balance Sheet > total Assets
29730000
Quarters > 2 > balance Sheet > payables
4347000
Quarters > 2 > balance Sheet > short Term Debt
1363000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11061000
Quarters > 2 > balance Sheet > equity
18669000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2732000
Quarters > 2 > cash Flow > depreciation
11000
Quarters > 2 > cash Flow > change In Working Capital
-149000
Quarters > 2 > cash Flow > cash From Operations
-2686000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
11143000
Quarters > 2 > cash Flow > net Change In Cash
8171000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.4509012354982365
Quarters > 2 > ratios > PB
0.06806732444158765
Quarters > 2 > ratios > ROE
-14.633885050083025
Quarters > 2 > ratios > ROA
-9.189371005718131
Quarters > 2 > ratios > FCF
-2686000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6000
Quarters > 3 > income Statement > cost Of Revenue
1000
Quarters > 3 > income Statement > gross Profit
-1000
Quarters > 3 > income Statement > operating Expenses
7317000
Quarters > 3 > income Statement > operating Income
-7317000
Quarters > 3 > income Statement > interest Expense
75000
Quarters > 3 > income Statement > pretax Income
-7453000
Quarters > 3 > income Statement > net Income
-7453000
Quarters > 3 > income Statement > eps
-4.729775181785066
Quarters > 3 > income Statement > dividends Per Share
228000
Quarters > 3 > income Statement > shares Outstanding
1575762
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-7377000
Quarters > 3 > income Statement > operating Margin
-121950
Quarters > 3 > income Statement > total Other Income Expense Net
-136000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
19533000
Quarters > 3 > balance Sheet > short Term Investments
72000
Quarters > 3 > balance Sheet > receivables
2229000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
22341000
Quarters > 3 > balance Sheet > property Plant Equipment
309000
Quarters > 3 > balance Sheet > total Assets
22650000
Quarters > 3 > balance Sheet > payables
4182000
Quarters > 3 > balance Sheet > short Term Debt
1350000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10839000
Quarters > 3 > balance Sheet > equity
11811000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-7453000
Quarters > 3 > cash Flow > depreciation
1000
Quarters > 3 > cash Flow > change In Working Capital
3906000
Quarters > 3 > cash Flow > cash From Operations
-3206000
Quarters > 3 > cash Flow > capital Expenditures
298000
Quarters > 3 > cash Flow > cash From Investing
-298000
Quarters > 3 > cash Flow > cash From Financing
4235000
Quarters > 3 > cash Flow > net Change In Cash
1070000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-4.729775181785066
Quarters > 3 > ratios > PB
0.15209285242570483
Quarters > 3 > ratios > ROE
-63.10219287105241
Quarters > 3 > ratios > ROA
-32.905077262693155
Quarters > 3 > ratios > FCF
-3504000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-584
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
9000
Annuals > 0 > income Statement > gross Profit
-9000
Annuals > 0 > income Statement > operating Expenses
27241000
Annuals > 0 > income Statement > operating Income
-27241000
Annuals > 0 > income Statement > interest Expense
653000
Annuals > 0 > income Statement > pretax Income
-24896000
Annuals > 0 > income Statement > net Income
-24515000
Annuals > 0 > income Statement > eps
-15.255238212582663
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1606989
Annuals > 0 > income Statement > income Tax Expense
-381000
Annuals > 0 > income Statement > EBITDA
-24234000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
2345000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
19533000
Annuals > 0 > balance Sheet > short Term Investments
72000
Annuals > 0 > balance Sheet > receivables
2229000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
22341000
Annuals > 0 > balance Sheet > property Plant Equipment
309000
Annuals > 0 > balance Sheet > total Assets
22650000
Annuals > 0 > balance Sheet > payables
4182000
Annuals > 0 > balance Sheet > short Term Debt
1350000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10839000
Annuals > 0 > balance Sheet > equity
11811000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-24515000
Annuals > 0 > cash Flow > depreciation
9000
Annuals > 0 > cash Flow > change In Working Capital
63000
Annuals > 0 > cash Flow > cash From Operations
-17352000
Annuals > 0 > cash Flow > capital Expenditures
298000
Annuals > 0 > cash Flow > cash From Investing
-298000
Annuals > 0 > cash Flow > cash From Financing
36792000
Annuals > 0 > cash Flow > net Change In Cash
19367000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-15.255238212582663
Annuals > 0 > ratios > PB
0.155106888493777
Annuals > 0 > ratios > ROE
-207.56074845483025
Annuals > 0 > ratios > ROA
-108.23399558498896
Annuals > 0 > ratios > FCF
-17650000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
37000
Annuals > 1 > income Statement > gross Profit
-37000
Annuals > 1 > income Statement > operating Expenses
17129000
Annuals > 1 > income Statement > operating Income
-17129000
Annuals > 1 > income Statement > interest Expense
498000
Annuals > 1 > income Statement > pretax Income
-11818000
Annuals > 1 > income Statement > net Income
-11901000
Annuals > 1 > income Statement > eps
-3515.805022156573
Annuals > 1 > income Statement > dividends Per Share
10995000
Annuals > 1 > income Statement > shares Outstanding
3385
Annuals > 1 > income Statement > income Tax Expense
83000
Annuals > 1 > income Statement > EBITDA
-11283000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5311000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
166000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
946000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1971000
Annuals > 1 > balance Sheet > property Plant Equipment
20000
Annuals > 1 > balance Sheet > total Assets
11862000
Annuals > 1 > balance Sheet > payables
8416000
Annuals > 1 > balance Sheet > short Term Debt
1300000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
14613000
Annuals > 1 > balance Sheet > equity
-2751000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-11901000
Annuals > 1 > cash Flow > depreciation
37000
Annuals > 1 > cash Flow > change In Working Capital
3352000
Annuals > 1 > cash Flow > cash From Operations
-12745000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
10995000
Annuals > 1 > cash Flow > net Change In Cash
-1863000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3515.805022156573
Annuals > 1 > ratios > PB
-0.0014027262813522353
Annuals > 1 > ratios > ROE
432.6063249727372
Annuals > 1 > ratios > ROA
-100.32878098128477
Annuals > 1 > ratios > FCF
-12745000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
120000
Annuals > 2 > income Statement > gross Profit
-120000
Annuals > 2 > income Statement > operating Expenses
34463000
Annuals > 2 > income Statement > operating Income
-34463000
Annuals > 2 > income Statement > interest Expense
223000
Annuals > 2 > income Statement > pretax Income
-17579000
Annuals > 2 > income Statement > net Income
-16058000
Annuals > 2 > income Statement > eps
-1416049.3827160494
Annuals > 2 > income Statement > dividends Per Share
1511000
Annuals > 2 > income Statement > shares Outstanding
11.34
Annuals > 2 > income Statement > income Tax Expense
-1521000
Annuals > 2 > income Statement > EBITDA
-17296000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
16884000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2029000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
871000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
4968000
Annuals > 2 > balance Sheet > property Plant Equipment
27000
Annuals > 2 > balance Sheet > total Assets
14544000
Annuals > 2 > balance Sheet > payables
6251000
Annuals > 2 > balance Sheet > short Term Debt
2660000
Annuals > 2 > balance Sheet > long Term Debt
1083000
Annuals > 2 > balance Sheet > total Liabilities
12654000
Annuals > 2 > balance Sheet > equity
1890000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-16058000
Annuals > 2 > cash Flow > depreciation
60000
Annuals > 2 > cash Flow > change In Working Capital
-328000
Annuals > 2 > cash Flow > cash From Operations
-16817000
Annuals > 2 > cash Flow > capital Expenditures
18000
Annuals > 2 > cash Flow > cash From Investing
791000
Annuals > 2 > cash Flow > cash From Financing
-1311000
Annuals > 2 > cash Flow > net Change In Cash
-17526000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1416049.3827160494
Annuals > 2 > ratios > PB
0.00000684
Annuals > 2 > ratios > ROE
-849.6296296296297
Annuals > 2 > ratios > ROA
-110.4097909790979
Annuals > 2 > ratios > FCF
-16835000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
106000
Annuals > 3 > income Statement > gross Profit
-106000
Annuals > 3 > income Statement > operating Expenses
26556000
Annuals > 3 > income Statement > operating Income
-26556000
Annuals > 3 > income Statement > interest Expense
640000
Annuals > 3 > income Statement > pretax Income
-26515000
Annuals > 3 > income Statement > net Income
-26648000
Annuals > 3 > income Statement > eps
-3520211.360634082
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7.57
Annuals > 3 > income Statement > income Tax Expense
133000
Annuals > 3 > income Statement > EBITDA
-25769000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
41000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
19555000
Annuals > 3 > balance Sheet > short Term Investments
350000
Annuals > 3 > balance Sheet > receivables
1345000
Annuals > 3 > balance Sheet > inventories
-1345000
Annuals > 3 > balance Sheet > total Current Assets
21404000
Annuals > 3 > balance Sheet > property Plant Equipment
94000
Annuals > 3 > balance Sheet > total Assets
49633000
Annuals > 3 > balance Sheet > payables
698000
Annuals > 3 > balance Sheet > short Term Debt
98000
Annuals > 3 > balance Sheet > long Term Debt
979000
Annuals > 3 > balance Sheet > total Liabilities
30849000
Annuals > 3 > balance Sheet > equity
18784000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-26648000
Annuals > 3 > cash Flow > depreciation
106000
Annuals > 3 > cash Flow > change In Working Capital
5570000
Annuals > 3 > cash Flow > cash From Operations
-15050000
Annuals > 3 > cash Flow > capital Expenditures
18000
Annuals > 3 > cash Flow > cash From Investing
1000000
Annuals > 3 > cash Flow > cash From Financing
33819000
Annuals > 3 > cash Flow > net Change In Cash
19257000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3520211.360634082
Annuals > 3 > ratios > PB
4.594229131175469e-7
Annuals > 3 > ratios > ROE
-141.86541737649063
Annuals > 3 > ratios > ROA
-53.69008522555557
Annuals > 3 > ratios > FCF
-15068000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
23
Valuation > metrics > PE
0.207
Valuation > metrics > PB
1.3989985846307549
Valuation > final Score
100
Valuation > verdict
49.0% Undervalued
Profitability > metrics > ROE
-23.361918241611857
Profitability > metrics > ROA
-13.710544317404475
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7314128715344268
Risk > metrics > Interest Coverage
-44.175438596491226
Risk > final Score
-129
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.4155540720961284
Liquidity > metrics > Quick Ratio
3.4155540720961284
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1330
Prev Risks > 1
-165
Prev Risks > 2
-342
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:22:19.384Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.19
Earnings History > 0 > eps Estimate
-0.21
Earnings History > 0 > eps Difference
0.02
Earnings History > 0 > surprise Percent
9.5238
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-15
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.15
Earnings History > 1 > eps Estimate
-0.21
Earnings History > 1 > eps Difference
0.06
Earnings History > 1 > surprise Percent
28.5714
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-09
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.25
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.72
Earnings History > 3 > eps Estimate
-0.14
Earnings History > 3 > eps Difference
-1.58
Earnings History > 3 > surprise Percent
-1128.5714
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.75
Earnings History > 4 > eps Estimate
-8.4
Earnings History > 4 > eps Difference
6.65
Earnings History > 4 > surprise Percent
79.1667
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-3.3
Earnings History > 5 > eps Estimate
-8.7
Earnings History > 5 > eps Difference
5.4
Earnings History > 5 > surprise Percent
62.069
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-664.2007
Earnings History > 6 > eps Estimate
-52.8001
Earnings History > 6 > eps Difference
-611.4006
Earnings History > 6 > surprise Percent
-1157.9535
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-08
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.43
Earnings History > 7 > eps Estimate
-0.25
Earnings History > 7 > eps Difference
-0.18
Earnings History > 7 > surprise Percent
-72
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-2.24
Earnings History > 8 > eps Estimate
-8.17
Earnings History > 8 > eps Difference
5.93
Earnings History > 8 > surprise Percent
72.5826
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-26.28
Earnings History > 9 > eps Estimate
-11.19
Earnings History > 9 > eps Difference
-15.09
Earnings History > 9 > surprise Percent
-134.8525
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-7.88
Earnings History > 10 > eps Difference
7.6
Earnings History > 10 > surprise Percent
96.4467
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-13
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.42
Earnings History > 11 > eps Difference
0.19
Earnings History > 11 > surprise Percent
45.2381
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.68
Earnings History > 12 > eps Estimate
-0.25
Earnings History > 12 > eps Difference
-0.43
Earnings History > 12 > surprise Percent
-172
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-22
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.52
Earnings History > 13 > eps Estimate
-0.42
Earnings History > 13 > eps Difference
-0.1
Earnings History > 13 > surprise Percent
-23.8095
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-27
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-17.1
Earnings History > 14 > eps Estimate
-0.66
Earnings History > 14 > eps Difference
-16.44
Earnings History > 14 > surprise Percent
-2490.9091
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2021-12-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-999999.9999
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-12-21
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.12
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.12
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-30
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0079
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0079
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.059
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.059
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0126
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0126
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0165
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0165
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0072
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0072
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0045
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0045
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0182
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0182
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.1549
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.1549
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0453
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0453
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0577
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0577
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0394
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0394
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.0469
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.0469
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0109
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0109
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.0423
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.0423
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0258
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.0258
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-12-31
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0256
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0256
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-09-30
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.0476
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.0476
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-06-30
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0435
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.0435
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-31
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.1284
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.1284
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-12-31
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.1676
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-0.1676
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-09-30
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.1018
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.1018
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-06-30
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.0661
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
-0.0661
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-03-31
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.0827
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
-0.0827
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-12-31
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.0845
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
-0.0845
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-09-30
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.0437
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
-0.0437
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-06-30
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.0241
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
-0.0241
Earnings History > 42 > surprise Percent
-
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShort Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Declines By 17.1% - Defense World
1/19/2026
Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Declines By 17.1% Defense World
Read more →Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) - Defense World
1/13/2026
Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$9.25
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 2.74% of the total shares of Allarity Therapeutics Inc
1.
Vanguard Institutional Extnd Mkt Idx Tr(0.6142%)
since
2025/07/31
2.
XTX Topco Ltd(0.3485%)
since
2025/06/30
3.
Geode Capital Management, LLC(0.3465%)
since
2025/06/30
4.
Fidelity Extended Market Index(0.3321%)
since
2025/07/31
5.
UBS Group AG(0.3282%)
since
2025/06/30
6.
Jane Street Group LLC(0.1803%)
since
2025/06/30
7.
Fidelity Total Market Index(0.1525%)
since
2025/07/31
8.
Fidelity Series Total Market Index(0.1477%)
since
2025/07/31
9.
Spartan Extended Market Index Pool F(0.1064%)
since
2025/07/31
10.
Squarepoint Ops LLC(0.0988%)
since
2025/06/30
11.
Spartan Total Market Index Pool G(0.0533%)
since
2025/07/31
12.
Tower Research Capital LLC(0.021%)
since
2025/06/30
13.
Citigroup Inc(0.0101%)
since
2025/06/30
14.
Bank of America Corp(0.0009%)
since
2025/06/30
15.
Advisor Group Holdings, Inc.(0%)
since
2025/06/30
16.
Goldman Sachs Group Inc(0%)
since
2025/03/31
17.
Corsair Capital Management LLC(0%)
since
2025/06/30
18.
Barclays PLC(0%)
since
2025/06/30
19.
Stonepine Capital Management Llc(0%)
since
2025/03/31
20.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.19
EPS Estimate
-0.21
EPS Difference
0.02
Surprise Percent
9.5238%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.